![Erin Burkhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 811 971 $ al 31/05/2026
Erin E.
Burkhart is Chief Accounting Officer, Senior VP & Controller at Gilead Sciences, Inc. starting in 2025.
Former roles include Chief Accounting Officer & Group Vice President at BioMarin Pharmaceutical, Inc. from 2022 to 2025, and Associate VP-US Gross-to-Net Business Analysis at Eli Lilly & Co. from 2021 to 2022.
Education includes undergraduate studies at Butler University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/05/2025 | 14.173 ( 0,01 % ) | 811 971 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GILEAD SCIENCES, INC. | Comptroller/Controller/Auditor | 22/09/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Comptroller/Controller/Auditor | 02/09/2025 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/04/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Butler University
 Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
